French health tech Doctolib is in talks to raise a large secondary investment, in the range of a few hundred million dollars, where Generation Investment Management would buy a stake from existing shareholders, three sources told Forbes.

Doctolib reached a valuation of $6.4 billion at its most recent venture funding in March 2022, making it the highest valued French startup at the time (that crown has since been taken by AI startup Mistral, now worth $14 billion). One source said........

© Forbes